# Michael Lissy, M.D. – FDA Inspection, May 9, 2025

Source: https://www.keypedia.com/records/fda_inspections/michael-lissy-md/71861a50-0acf-4b9f-8086-a64d9324c204
Source feed: FDA_Inspections

> FDA inspection 1269694 of Michael Lissy, M.D., May 09, 2025. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269694
- Company Name: Michael Lissy, M.D.
- Inspection Date: 2025-05-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Officers

- [Company Rep](https://www.keypedia.com/people/karen-m-montgomery/ee91b1bb-8d51-4fdc-bee5-949441136e59)

Company: https://www.keypedia.com/companies/michael-lissy-md/00203348-d0ad-49a3-a49d-6c54f6e9f834

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
